Skip to main content

Table 7 Pancancer and cancer-specific labels used for clinical label enrichment analysis. Pathological M, N and T labels refer to the TNM staging system, which describes the anatomical extent of tumor cancers [25]

From: Consensus clustering applied to multi-omics disease subtyping

Pan-cancer Age at initial pathologic diagnosis, Gender, Pathologic M, Pathologic N, Pathologic T, Pathologic stage, Histological type, New neoplasm event type, Neoplasm histologic grade
AML CALGB cytogenetics risk category, FAB morphology code
BIC PAM50Call RNAseq, Estrogen receptor status, Progesterone receptor status, ER level cell percentage category, PR level cell percentage category
COAD Presence of colon polyps, History of colon polyps
GBM Prior glioma
KIRC Hemoglobin result, Platelet qualitative result, Serum calcium result, White cell count result
LIHC Adjacent hepatic tissue inflammation extent type, Albumin result specified value, Creatinine value, Fetoprotein outcome value, Fibrosis ishak score
LUSC Tobacco smoking history, Number pack years smoked
OV No supplementary clinical label
SARC No supplementary clinical label
SKCM Melanoma Clark level value, Melanoma ulceration indicator